In some cases, users may experience mild flu-like symptoms fatigue, headache, nausea especially at the onset of treatment
Burg D, Filippov DV, Hermanns R, van der Marel GA, van Boom JH, Mulder GJ
Supplementation may be indicated for individuals with dietary restrictions, certain health conditions, or increased nutritional requirements
Analytical procedures and methods validation for drugs and biologics
Vomiting: Persistent vomiting, along with diarrhea, increases the risk of dehydration and may require medical intervention
HSP90 inhibitors such as ganetespib (STA-9090) and AUY922 have been extensively evaluated in oncology, 54,55 where they disrupt the stabilization of oncogenic client proteins